COPD Dr.S.Nandakumar. Professor of Medicine FOM, AIMST.

Slides:



Advertisements
Similar presentations
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Pathophysiology of COPD and Asthma
Academy Board Prep PCCM
Disorders of the respiratory system 2
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Asthma and COPD Roger Deering + Phil Thirkell. Asthma - Definition A chronic inflammatory disorder of the airways… Symptoms usually associated with variable.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Applied Epidemiology Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) By Chris Callan 23 April 2008.
By: E. Salehifar Clinical Pharmacist
COPD (Chronic Obstructive Pulmonary Disease)
ASTHMA AND COPD By Jess Laidlaw. Overview 1)Asthma 2)COPD 3)Comparison.
 Chronic obstructive pulmonary disease (COPD) is one of the most common lung disease  Makes it difficult to breathe  There are two main forms of COPD.
Disorders of the respiratory system. Respiratory structures such as the airways, alveoli and pleural membranes may all be affected by various disease.
Chronic Lower Respiratory Diseases. Two main Types Discussed Today Chronic Obstructive Pulmonary Disease (COPD) Asthma.
Management of Patients With Chronic Pulmonary Disease.
Chronic Obstructive Pulmonary Disease Natasha Chowdhury.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Definition of COPD COPD is defined by GOLD (2014 update) as:*
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
Chronic Obstructive Pulmonary Disease and Asthma: All That Wheezes? Clifford Courville, MD Pulmonary, Allergy, and Critical Care.
Bronchial asthma L de Man Dept of Physiotherapy UFS 2012.
COPD Review. Progressive Syndrome Expiratory airflow obstruction Chronic airway and lung parenchyma inflammation.
World COPD Day 2005 Slide Kit
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
Chronic Obstructive Pulmonary Disease Dr. Pawan K. Mangla, M.D., INTENSIVIST & PULMONOLOGIST ISIC & PSRI HOSPITAL Brought to you by IJCP Group of Publications.
Chronic Obstructive Pulmonary Disease
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Copyright © 2008 Wolters Kluwer Health | Lippincott Williams & Wilkins Emphysema Abnormal distention of air spaces beyond the terminal bronchioles with.
يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11 بسم الله الرحمن الرحیم با سلام.
 Definition  Asthma is a chronic inflammatory disorder of the lung airways, characterised by reversible airway obstruction, airway hyper-responsiveness,
Definition COPD def- A disease state characterized by air flow limitation that is not fully reversible It is expected to be the 3 rd leading cause of.
Asthma Diagnosis: Anatomy and Pathophysiology of Asthma Karen Meyerson, MSN, RN, FNP-C, AE-C Asthma Network of West Michigan April 21, 2009 Acknowledgements:
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Chronic Obstructive Lung Diseases (COPD) Lecture
Chronic Obstructive Pulmonary Disease
Advanced Asthma Training Course Mechanisms Of Asthma Part II Dr.Hadeel A.K AlOtair ABIM,MRCP(UK),FCCP Assisstant professor of Medicine consultant pulmonologist.
OBSTRUCTIVE AIRWAY DISEASE
Bronchial asthma By Dr. Abdelaty Shawky Assistant professor of pathology.
Chronic Obstructive Pulmonary Disease Austin Paul K.
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Disorders of the Respiratory System By : Amir Ashkan Ashrafian M.D.
Disorders of the respiratory system 2. Bronchitis is an obstructive respiratory disease that may occur in both acute and chronic forms. Acute bronchitis:
Management of Patients With Chronic Pulmonary Disease
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
COPD (Chronic Obstructive Pulmonary Disease) By: Montana Martin.
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
بسم الله الرحمن الرحيم وَإِذَا مَرِضْتُ فَهُوَ يَشْفِينِ صدق الله العظيم الشعراء 80.
Chronic Obstructive Pulmonary Disease 연세대학교 의과대학 응급의학교실 강사 조준호.
Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Ignatavicius Chapter 32 Care of Patients with Noninfectious Lower Respiratory.
Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Asthma and COPD Part 2.
Asthma Review of Pathophysiology and Treatment. n definition of asthma –Asthma is a chronic inflammatory disorder of the airways in which many cells &
Chronic Obstructive Pulmonary Disease Clinacal Pharmacy.
Common Respiratory Problems: COPD Asthma, emphysema bronchitis.
Respiratory System Disorders
Chronic Obstructive Pulmonary Disease(COPD)
Management of Severe Asthma and COPD
Chronic Obstructive Pulmonary Disease
Disorders of the respiratory system
COPD Dr MAMATHA SARTHI GPST3.
Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and.
Chronic obstructive pulmonary disease
Chronic Obstructive Pulmonary Disease
Presentation transcript:

COPD Dr.S.Nandakumar. Professor of Medicine FOM, AIMST

Pre Test What is COPD ? What is Asthma ? How to differentiate these two ? Main etiology for COPD Symptoms ? Name two drugs used to treat COPD ?

Facts About COPD Cigarette smoking is the primary Cause of COPD. The WHO estimates 1.1 billion smoker worldwide, increasing to 1.6 billion by 2025 in low middle-income countries. In 2000,the WHO estimated 2.74 million deaths worldwide from COPD. In 2020 COPD will be the 3rd most common cause of death

Chronic Obstructive Pulmonary Disease (COPD) COPD is a disease state characterized by airflow limitation that is not fully reversible. The airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases and associated with systemic manifestations. This definition does not use the terms chronic bronchitis and emphysema and excludes asthma (reversible airflow limitation).

Diagnosis of COPD It should be considered in patients over the age of 35 who have a risk factor, generally smoking, and who present with exertional dyspnoea, chronic cough, regular sputum production, frequent bronchitis or wheeze. The presence of airflow obstruction should be confirmed by performing spirometry.

Chronic Obstructive Pulmonary Disease (COPD) Chronic bronchitis Defined as the presence of cough and sputum production for at least 3 months in each of 2 consecutive years, is not necessarily associated with airflow limitation. Emphysema Defined as destruction and dilatation of the alveoli, is a pathological term that is sometimes (incorrectly) used clinically. Chronic bronchitis without airflow limitation is not included in COPD

Disease Trajectory of a Patients with COPD Symptoms Exacerbations Deterioration End of Life

Risk Factors Cigarette smoking Hyper responsiveness of airways Infection- ??? childhood Occupational exposure ??? Air pollution ??? Passive smoking Alpha 1 anti trypsin deficiency

Pathophysiology Smoking - activates macrophage – cytokines – inflammation Smoking – mucous gland hyperplasia – metaplasia - excess mucous production – edema – airway narrowing Reduced surfactant – airway narrowing or collapse Fibrosis

Pathophysiology of COPD Airflow obstruction – reduced FEV1/FVC ( COPD Vs BA ) Air trapping due to loss of elastic recoiling -– hyperinflation – impaired respiration Non uniform ventilation leads to ventilation perfusion mismatch -hypoxemia

Figure 7. 24 Diagrammatic representation of breath sounds Figure 7.24 Diagrammatic representation of breath sounds. (A) Vesicular. (B) Bronchial. Note the gap between inspiration and expiration and change in pitch and the blowing, tubular quality of bronchial breath sounds. © 2005 Elsevier 11

Figure 5.48 Timing of vesicular breathing. © 2005 Elsevier 12 12

Figure 5.49 Timing of bronchial breathing. © 2005 Elsevier 13 13

ASTHMA & COPD Asthma COPD Asthma COPD Onset in mid-life. Symptoms slowly progressive. Long smoking history. Dyspnoea during exercise. Largely irreversible airflow limitation. COPD Asthma COPD Onset early in life (often childhood). .Symptoms vary from day to day. .Symptoms at night/early morning. .Allergy, rhinitis, and/or eczema also present. .Family history of asthma. .Largely reversible airflow limitation. Asthma

Comparisons of asthma & COPD CD 4+ lymphocytes eosinophils mast cells Vary over time and in severity cough wheeze breathlessness chest tightness COPD CD 8+ lymphocytes macrophages neutrophils Persistent and progressive over time cough Wheeze Breathlessness sputum Patho- physiology: chronic inflammation Clinical history: symptoms Slide 8 • COPD differs from asthma in both the type of inflammation involved and in the pattern of respiratory symptoms caused

Risk factors that lead to asthma development Predisposing Factors atopy gender indoor allergens - dust mites - pet animal - cockroach - fungi outdoor allergens - pollens - fungi occupational sensitizers Contributing Factors respiratory infections diet air pollution - outdoor - indoor Smoking - passive - active Slide 18 GINA, Guidelines 1998

Common occupational agents flour / grain dust (bakery) paint, glue or plastic fumes soldering flux natural rubber latex wood dust Slide 19 • A large number of agents encountered in the workplace may provoke or exacerbate asthma • Some agents induce allergic asthma through stimulating the formation of a specific serum IgE (taking many years to cause the disease); some cause an immediate antigen-antibody response and others result in airway hyperresponsiveness because of a direct irritant effect on the airway wall • Typically, PEF measurements improve as soon as the patient is away from the workplace

Asthma - an inflammatory disease Normal Asthma Slide 13 • Asthma is a chronic inflammatory disorder of the airways • This bronchoscopic view of an airway shows the normal appearance of a healthy airway, contrasted with inflammation (reddening and swelling) and narrowing of the asthmatic airway • Microscopic examination of biopsy and lavage samples taken through the bronchoscope has established that inflammatory changes are present in asthma of all grades of severity, including recently diagnosed asthma

Inducers Inflammation Airway Hyperresponsiveness Airflow Limitation Allergens, Chemical sensitisers, Air pollutants, Virus infections Inflammation Triggers Allergens, Exercise Cold Air, SO2 Particulates Symptoms Cough Wheeze Chest tightness Dyspnoea Airway Hyperresponsiveness Airflow Limitation Slide 16 • Inflammation of the airways not only causes symptoms associated with widespread, variable airflow obstruction, it also results in an increase in airway hyperresponsiveness to a variety of stimuli (triggers) • Environmental and genetic influences in asthma (inducers) act mainly by provoking airway inflammation, rather than directly stimulating airway hyperresponsiveness • Triggers of bronchoconstriction, which are factors that provoke contraction of the sensitised airway wall, include a wide range of stimuli, such as exercise, cold air and pollen • Allergens can act as both inducers and triggers Barnes PJ

Indicators for Considering a COPD Diagnosis   Indicators for Considering a COPD Diagnosis Chronic cough Present intermittently or every day. Often present throughout the day; seldom only nocturnal. Chronic sputum production Any pattern of chronic sputum production may indicate COPD. Acute bronchitis Repeated episodes. Dyspnoea that is Progressive (worsens over time). Persistent (present every day). Worse on exercise. Worse during respiratory infections. History of exposure to risk factors Tobacco smoke …. (including popular local preparations). Occupational dusts and chemicals. Smoke from home cooking and heating fuel. CLINICAL FEATURES OF COPD

Clinical features – physical examination Early stage – no findings Barrel chest Pursed lip breathing Tripod position Prolonged expiratory phase & wheeze Predominant emphysema – pink puffers Ch. Bronchitis – blue bloaters Signs of right heart failure

Diagnosis Of COPD SPIROMETRY The diagnosis should be confirmed by When performing spirometry, measure: Forced Vital Capacity (FVC) and Forced Expiratory Volume in one second (FEV1). Calculate the FEV1/FVC ratio. Patients with COPD typically show : a decrease in both FEV1 and FEV1/FVC With limited/no reversibility after bronchodilators However, both symptoms and spirometry should be considered when developing an individualized management strategy for each patient.

Assessment of severity of COPD MILD AIRFLOW OBSTRUCTION MODERATE AIRFLOW OBSTRUCTION SEVERE AIRFLOW OBSTRUCTION FEV1 50-80% PREDICTED FEV1 30-49% PREDICTED FEV1 <30% PREDICTED

Other tests… ABG X ray chest CT thorax Alpha 1 AT

GOLD Classification of COPD Stage 0 At Risk normal spirometry Chronic symptoms (cough and sputum production) Stage I Mild COPD FEV1 / FVC < 70% but FEV1 > or equal to 80 % predicted With or without chronic symptoms cough and sputum production. Stage II Moderate COPD :FEV1/FVC<70% 30% < or equal FEV1<80% predicted (IIA:50% < or equal FEV1<80% ) (IIB:30% < or equal FEV1<50% ) With or without chronic symptoms (cough, sputum production and dyspnea) Stage III Severe COPD FEV1 /FVC < 70% FEV1 < 30% predicted or FEV1 <50% predicted +presence of respiratory failure or clinical signs of right heart failure. At this stage, quality of life is very impaired and exacerbations may be life-threatening.

Goals of COPD management Prevent disease progression . Relieve symptoms. Improve exercise tolerance. Prevent and treat complications. Reduce mortality.

Assess and Monitor Disease A detailed medical history. Spirometry. Chest X-ray. Arterial blood gas measurement. Alpha-1 antitrypsin deficiency screening.

Smoking cessation is the single most effective And cost-effective – Reduce Risk Factors Smoking cessation is the single most effective And cost-effective – intervention to reduce the risk of developing COPD and slow its progression – nicotine patch or Bupropion Smoking Prevention Avoid occupational Exposures

Management of stable COPD Patient education. Pharmacologic Treatment. - Bronchodilators, - Corticosteroids, - Antibiotics, - Mucolytic -- Respiratory Stimulants Non-Pharmacologic Treatment - Rehabilitation, - Oxygen Therapy, - Surgical Treatments (Bullectomy)

“Bronchodilator medications are central to the symptomatic management of COPD” GOLD Report 2003

How Do Bronchodilators Work? Reverse the increased bronchomotor tone Relax the smooth muscle Reduce the hyperinflation Improve breathlessness

“All guidelines recommend inhaled bronchodilator as first line therapy. Chest 2000; 117: 23S-28S

Mode of Action Increased cholinergic tone is the only reversible component of COPD Normal airways have less degree of vagal cholinergic tone

Mode of Action (Contd.) Therefore, the need for anticholinergic drugs that will act as muscarinic receptor antagonist and block the acetylcholine induced bronchoconstriction

Mode of Action (Contd.) Anticholinergics may also reduce mucus hypersecretion Anticholinergic have no effect on pulmonary vessels, and therefore do not cause a fall in PaO2 Drugs of Today 2002; 38(9): 585-600

“Combining bronchodilators with different “Patients with moderate to severe symptoms of COPD require combination of bronchodilators” “Combining bronchodilators with different mechanisms and durations of actions may increase the degree of bronchodilation GOLD Report 2003

Algorithm for the management of COPD Mild Short acting bronchodilator – as required Tiotropium Long acting beta agonist assess with symptoms and spirometry Tiotropium+LABA LABA + tiotropium Add -Inhaled steroids -Theophylline Severe

Management Of Acute Exacerbation Home Management Bronchodilators: Increase dose and/or frequency of existing bronchodilator therapy. Can add anticholinergic until symptoms improve. Glucocorticosteroids: If baseline FEV1 < 50% predicted, add 40 mg oral prednisolone per day for 10 days to the bronchodilator regimen. Antibiotics: When symptoms of breathlessness and cough are increased and sputum is purulent and increased in volume, provide antibiotic coverage , taking into account local patterns of antibiotic sensitivity.

Indications for Hospital Admission for Acute Exacerbations .Marked increase in intensity of symptoms, such as sudden development of resting dyspnea Onset of new physical signs (e.g. Cyanosis, peripheral edema) Failure of exacerbation to respond to initial medical management Newly occurring arrhythmias .Older age

Management of acute exacerbation Bronchodilators + anticholinergics Antibiotics Corticosteroids Oxygen Mechanical ventilation

Carry home message.. Definition COPD v ASTHMA Risk factors Clinical features Management

Thank you